Table 7.
Adjusted regression model estimates of the association between plasma apoC-II, apoC-III, and surrogate markers of CV risk.
| Dependent variable | Explanatory variable | Adjusteda | Model | ||
|---|---|---|---|---|---|
| Beta | p-Value | r | p-Value | ||
| 24-h SBP | ApoC-II | 0.269 | 0.004 | 0.543 | <0.001 |
| 24-h DBP | ApoC-II | 0.209 | 0.037 | 0.423 | <0.001 |
| Awake SBP | ApoC-II | 0.27 | 0.006 | 0.479 | <0.001 |
| Asleep SBP | ApoC-II | 0.253 | 0.011 | 0.437 | <0.001 |
| Awake DBP | ApoC-II | 0.233 | 0.021 | 0.407 | <0.001 |
| Diastolic BP load | ApoC-II | 0.261 | 0.011 | 0.391 | 0.001 |
| LVMI | ApoC-II | 0.218 | 0.033 | 0.375 | 0.002 |
| 24-h hypertension | ApoC-III | 0.303 | 0.003 | 0.425 | <0.001 |
| Awake hypertension | ApoC-III | 0.209 | 0.039 | 0.421 | 0.001 |
| Asleep hypertension | ApoC-III | 0.379 | <0.001 | 0.379 | <0.001 |
LVMI, left ventricular mass index; apoC-II, apolipoprotein C-II; apoC-III, apolipoprotein C-III; CV, cardiovascular; SBP, systolic blood pressure; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; CAKUT, congenital anomalies of the kidney and urinary tract.
Adjusted for age, sex, eGFR, and CAKUT.